25Serious

Paul Martin

Paul Martin

Ask VT AI

View News Summary

Trump touts 'perfect' MRI results, won't rule out 2028 run, and takes aim at Democratic figures
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Trump touts 'perfect' MRI results, won't rule out 2028 run, and takes aim at Democratic figures
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Paul Martin